Mike Yates is a senior leader at Bayer Aktiengesellschaft with extensive experience in shaping global market strategies and launch readiness. He specializes in leveraging market insights, trend analysis, and cross-functional collaboration to anticipate healthcare system changes and translate them into actionable strategies. Passionate about innovation and patient-centricity, Mike has led multiple initiatives that align business objectives with evolving healthcare realities, driving sustainable impact and launch success across therapeutic areas.

Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population. At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses. Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by empowering everyday health, improving approaches to patient care, and finding better ways to nourish our communities around the world.